PhRMA Foundation/LinkedIn
May 10, 2026, 09:43
New Research Targets Immune Pathways Behind Blood Clots in APS – PhRMA Foundation
PhRMA Foundation shared a post on LinkedIn:
“In antiphospholipid syndrome (APS), harmful antibodies trigger blood clots and inflammation – sometimes even when patients are on blood thinners. PhF26 awardee Thalia Newman of the University of Michigan is targeting the immune pathways behind this process to reduce risk of blood clots in APS.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 23, 2026, 17:19Oluyemisi Famuyiwa: Financing Your Fertility Treatment
-
Aug 23, 2026, 17:11Favour Ayomi: The Questions That Changed Reproductive Science
-
Aug 23, 2026, 16:54Chang-Hoon Cho: A Comprehensive Immune Atlas of the Human Endometrium
-
Aug 23, 2026, 16:42Sharing Shannon’s Story with Preeclampsia This Story Saturday – Preeclampsia Foundation
-
Aug 23, 2026, 16:36Sarah Lewen: The More Capable the Machines Become, the More Human Connection Matters
-
Aug 23, 2026, 16:31Chandana A։ Why Good-Quality Embryos Sometimes Don’t Implant
-
Aug 23, 2026, 16:28Negin Asadi։ How Does the Blastocyst Attach to the Uterus?
-
Aug 23, 2026, 16:22Christopher Robinson։ Ultrasound Images of Scar and Cesarean Scar Defects
-
Aug 23, 2026, 16:17Somya Jha։ ICSI – 1 Sperm, 1 Egg, 1 Tiny Needle